Flexion Therapeutics, Inc. Operating Cash Flow
Flexion Therapeutics, Inc. reported Operating Cash Flow of -$51.44 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2021-11-12
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$14.21M.
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$18.76M.
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-03-31 was -$18.47M.
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-12-31 was -$9.74M.
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$70.56M.
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was -$148.76M.
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$160.42M.
- Flexion Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2016 was -$62.47M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$14.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$32.97M derived: sum of 2 quarters · filed 2021-11-12 | -$51.44M 10-Q · filed 2021-11-12 | -$61.18M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$18.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$37.24M 10-Q · filed 2021-08-04 | -$46.98M derived: sum of 3 quarters · filed 2021-08-04 | -$59.19M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | -$18.47M 10-Q · filed 2021-05-12 | -$28.22M derived: sum of 2 quarters · filed 2021-05-12 | -$40.43M derived: sum of 3 quarters · filed 2021-11-12 | -$60.84M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | -$9.74M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$21.95M derived: sum of 2 quarters · filed 2021-11-12 | -$42.36M derived: sum of 3 quarters · filed 2021-11-12 | -$70.56M 10-K · filed 2021-03-10 |
| 2020-09-30 | -$12.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$32.62M derived: sum of 2 quarters · filed 2021-11-12 | -$60.82M 10-Q · filed 2021-11-12 | -$99.76M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$20.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$48.61M 10-Q · filed 2021-08-04 | -$87.55M derived: sum of 3 quarters · filed 2021-08-04 | -$119.00M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$28.20M 10-Q · filed 2021-05-12 | -$67.14M derived: sum of 2 quarters · filed 2021-05-12 | -$98.59M derived: sum of 3 quarters · filed 2021-05-12 | -$138.97M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$38.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$70.39M derived: sum of 2 quarters · filed 2021-03-10 | -$110.78M derived: sum of 3 quarters · filed 2021-03-10 | -$148.76M 10-K · filed 2021-03-10 |
| 2019-09-30 | -$31.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$71.83M derived: sum of 2 quarters · filed 2020-11-04 | -$109.82M 10-Q · filed 2020-11-04 | -$152.47M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -$40.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$78.36M 10-Q · filed 2020-08-05 | -$121.02M derived: sum of 3 quarters · filed 2021-03-10 | -$156.76M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -$37.98M 10-Q · filed 2020-05-07 | -$80.64M derived: sum of 2 quarters · filed 2021-03-10 | -$116.37M derived: sum of 3 quarters · filed 2021-03-10 | -$153.42M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -$42.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$78.39M derived: sum of 2 quarters · filed 2021-03-10 | -$115.44M derived: sum of 3 quarters · filed 2021-03-10 | -$160.42M 10-K · filed 2021-03-10 |
| 2018-09-30 | -$35.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$72.78M derived: sum of 2 quarters · filed 2019-11-07 | -$117.76M 10-Q · filed 2019-11-07 | -$159.65M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | -$37.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$82.03M 10-Q · filed 2019-08-06 | -$123.92M derived: sum of 3 quarters · filed 2020-05-20 | -$147.62M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | -$44.98M 10-Q · filed 2019-05-08 | -$86.87M derived: sum of 2 quarters · filed 2020-05-20 | -$110.57M derived: sum of 3 quarters · filed 2020-05-20 | |
| 2017-12-31 | -$41.89M derived: 8-K 12 month − 10-Q 9 month · filed 2020-05-20 | -$65.59M derived: sum of 2 quarters · filed 2020-05-20 | -$107.83M 8-K · filed 2020-05-20 | |
| 2017-09-30 | -$23.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$65.94M 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | -$42.24M 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | -$62.47M 10-K · filed 2019-02-28 |